echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Drugs are being transferred out of the health insurance catalogue, and another 186 drugs will be eliminated

    Drugs are being transferred out of the health insurance catalogue, and another 186 drugs will be eliminated

    • Last Update: 2020-06-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On June 4,
    the Medical Insurance Bureau of Guangxi Zhuang Autonomous Region issued a notice on the adjustment of the "Guangxi Basic Medical Insurance, Industrial Injury Insurance and Maternity Insurance Drug Catalog" on June 4It is clearly stated that, from June 1st, the original Guangxi basic medical insurance, industrial injury insurance and maternity insurance drugs paid within the scope of the provisions of the drug gradually digested within three years, the unified implementation of the national basic medical insurance, industrial injury insurance and maternity insurance drug catalogueAfter combing, the author found that in Guangxi this adjustment norms western medicine, traditional Chinese medicine part, there are 144 drugs were transferred out of the Western medicine part, 42 drugs were transferred out of the traditional Chinese medicine partIn addition, a large number of drugs have been required to implement limited payment coverage in accordance with the national 2019 drug catalogue, and a small number of drugs have been partially reimbursed dosage formsin fact, this time Guangxi adjusted the health insurance catalog, but the local addition of medical insurance varieties digesting accelerated a representativeIn recent years, many provinces have moved large quantities of drugs out of their local health-care listsespecially in 2019, the National Health Insurance Administration officially issued a new version of the National Health Insurance Directory, in the "clear local authority" a clear lying: "For the original provincial drug catalog in accordance with the provisions of the increase of Class B drugs, should be gradually digested within 3 years", "provinces should be given priority to be included in the scope of national key monitoring of drugs adjusted to pay the scope of payment" As of January 1 this year, the country began to formally implement the "National Basic Medical Insurance, Industrial Injury Insurance and Maternity Insurance Drug Catalog", such as Jiangxi, Shandong, Beijing, Hunan, Sichuan, Guangdong, Tianjin, Zhejiang and other places have been issued, to carry out the provincial directory and the new version of the national medical insurance directory docking workMany regions have also begun to add and divert large quantities of medicinesfor example, in March this year, Jiangxi Province issued the "Jiangxi Province transitional period to retain the drug catalog." According to the catalogue, Jiangxi Province will implement the deployment requirements of the State Medical Insurance Administration on "for the number of Class B drugs added in the original provincial drug catalogue, which should be gradually digested within three years" and make working arrangements for the retention of drugs during the transition period in the provincefrom the list, clear transitional retention includes, beyond the "National New Edition Directory" of 22 Western medicine, 46 traditional Chinese medicine, the implementation of more than the "National New Edition Directory" of drugs of medical insurance, work injury payment fund special managementThe remaining medicines are deleted or listed at their own expenseIt is worth noting that the state's key monitoring drugs must be withdrawn from the catalogue at one time, a total of 275 drugsin general, I believe that in the future there will be more provinces in the future, the State Health Insurance Bureau "gradually digest the provincial supplementary drugs" to implement the implementation of the measures, and drugs transferred out, supplementary health insurance catalog will also become the norm The relevant pharmaceutical companies only actively embrace the national policy, should do consistency evaluation to do consistency evaluation, should do innovation to do innovation, in order to win from the competition.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.